Søgning på udtrykket 'hiv' giver 92 resultater
Dokumenter [12]
Sider [7]
Kalender [29]
Nyt fra tidsskrifterne [+20]
Aktuelle smitsomme sygdomme [+20]
Dokumenter [12]
Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).
Endelig guideline: 01.09.2020
Version: 3
Guideline skal revideres senest: 01.09.2023
Arbejdsgruppens medlemmer: Peer Brehm Christensen, Christian Erikstrup, Jan Gerstoft, Terese Katzenstein, Alex Laursen, Suzanne Lunding, Birgitte Mørn og Nina Weis.
Arbejdsgruppen bestod af: Jan Gerstoft, Ann-Brit Eg Hansen, Gitte Kronborg, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen, Niels Obel og Alex Laursen
Fællesregional retningslinje for udlevering af forebyggende medicin mod HIV (PrEP), udgivet af Danske Regioner.
Europæisk guideline om hvornår, der bør testes for HIV. Udgivet af "HIV in Europe", et paneuropæisk initiativ for tidligere diagnosticering og behandling af HIV.
Anbefaling for profylakse og opfølgning af stikuheld og anden blodeksposition.
Arbejdsgruppe: Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis
Senest revideret september 2021 . Arbejdsgruppen bestod af: Jan Gerstoft, Gitte Kronborg , Ann Brit Eg Hansen, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen , Niels Obel og Alex Laursen
Arrangeret af Yngre Infektionsmedicinere
Henvendelse til Danske regioner
I forbindelse med Sundhedsstyrelsens udgivelse af "Personer med øget risiko ved COVID-19. Fagligt grundlag", har DSI beskrevet følgende specialespecifikke patienter med øget risiko for et alvorligt COVID-19 sygdomsforløb.
Sider [7]
Formål:
At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme.
Tid og sted:
Hvidovre Hospital. Lokale 10 i undervisningsbygningen.
Delkursusledere:
Ann-Brit Eg Hansen og Ole Kirk.
Program:
Mandag 3. oktober:
10:00-10:15 Velkomst og introduktion (Ann-…
…me og biologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…
…æsentanter i diverse arbejdsgrupper og udvalg, og publicerede guidelines.
Antiretroviral terapi:
Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Olav Larsen, Gitte Kronborg, Ann-Brit Eg Hansen
Antiviral behandling af hiv smittede personer,
Fertilitetsbehandling ved HIV og hepatitis B og C,
HIV behandling af gravide,
HIV post exposure profylakse (PEP),
Pre-exposure profylakse mod HIV (PrEP),
Borrelia:
Anne-Mette Lebech, Sigurdur Skarphedinsson
…
…eptember 2021
Gastroenterologiske infektioner og kronisk hepatitis:
Dato for næste kursus
Efterår 2023:
Sted
Hvidovre Hospital
Delkursusledelse
Morten Helms. Peer Brehm Christensen
Tidligere kurser
3. og 4. december 2020
HIV-infektion:
Dato for næste kursus
12. og 13. oktober 2022 (2 dage):
Sted
Endnu ikke afklaret
Delkursusledelse
Ole Schmeltz Søgaard og Lene Ryom Nielsen
Tidligere kurser
7. og 8. oktober 2019
3. og 4. oktober 2016
Immundefekt og…
…me og biologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…
Formål:
Rejsefondens formål er at yde økonomisk støtte til lægelige medlemmer af DSI med henblik på deltagelse på følgende kongresser: NSCMID, ECCMID, IDWeek, HIV og Hepatitis Nordic Conference, EACS/Glasgow HIV og CROI.
Hvad kan der søges om?
Der kan søges om økonomisk støtte til registreringsafgift, rejseudgifter og indlogering til de respektive kongresser. Det er ikke et krav at man har et videnskabeligt bidrag på kongressen.
Man kan højest få tildelt støtte til én kongres årligt. …
Kalender [29]
23. oktober, Glasgow, Skotland
11. maj, Avignon, Frankrig
30. september 2021, Barcelona, Spanien
18. juli 2021, Berlin, Tyskland
28. oktober 2020, Paris, Frankrig
25. oktober 2020, Glasgow, Skotland
7. oktober 2019, København
21. juli 2019, Mexico City, Mexico
22. maj 2019, Rom, Italien
13. maj 2019, København, Odense, Aarhus
28. oktober 2018, Glasgow, Skotland
30. maj 2018, Aarhus Universitshospital Skejby, gæstekantinen ved hovedindgangen, Palle Juul-Jensens Blvd. 99, Aarhus N
30. maj 2018, Rom, Italien
16. maj 2018, Marseille, Frankrig
25. april 2018, CHIP, Øster Allé 56, 5. sal (Persimune mødelokale), 2100 København Ø
8. juni 2017, Hvidovre Hospital
23. oktober 2016, Glasgow, Skotland
3. oktober 2016, Hvidovre Hospital
25. maj 2016, Rom, Italien
3. juni 2015, Barcelona, Spanien
2. november 2014, Glasgow, Skotland
22. april 2014, Auditorium 5, Hvidovre Hospital
26. marts 2014, Barcelona, Spanien
20. februar 2014, Rigshospitalet
20. marts 2013, Rom, Italien
14. januar 2013, Auditorium 2, Rigshospitalet
25. oktober 2012, Danmarks Medie- og Journalisthøjskole
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Current Opinion in Infectious Diseases
1.02.2022
Purpose of review . . The COVID-19 pandemic materialized in 2020, the year the international community had expected to meet the interim targets to end AIDS by 2030. Forty years into the HIV pandemic, the COVID-19 pandemic challenges the achievements made in HIV and may even reverse some of them. . Recent findings . . This article provides an overview of the impact of COVID-19 on people with, and at risk of, HIV infection. It addresses where the global response to HIV was expected to be by 2020, analyz…
Current Opinion in Infectious Diseases
1.02.2022
Purpose of review . . Cardiovascular diseases (CVD) is one of the leading cause of morbidity and mortality in antiretroviral treated people living with HIV (PWH) with risk score algorithms based on traditional risk factors being shown to be consistently unreliable in estimating risk in this population. This review aims to examine recent data published in last 18–24 months exploring biomarkers that may be useful in identifying PWH at risk of developing CVD. . Recent findings . . Ongoing research ex…
Current Opinion in Infectious Diseases
1.02.2022
Purpose of review . . The HIV population is ageing with rising rates of frailty though strategies of how best to manage it remain ill-defined. It also remains unclear what the prevalence of frailty is within this cohort, how best to diagnose it and what factors are associated. . Recent findings . . The prevalence of frailty remains unclear because of heterogenous results. Routine screening in those 50+ is recommended and whilst the Fried Frailty Phenotype is currently preferred the Clinical Frailty Sc…
Current Opinion in Infectious Diseases
1.02.2022
Purpose of review . . Despite improvements in the effectiveness of antiretroviral therapy (ART), there are still unmet needs for people living with HIV which drive the search for a cure for HIV infection. The goal of this review is to discuss the challenges and recent immunotherapeutic advances towards developing a safe, effective and durable cure strategy for HIV. . Recent findings . . In recent years, advances have been made in uncovering the mechanisms of persistence of latent HIV and in developing…
PLoS One Infectious Diseases
20.01.2022
by Workeabeba Abebe, Mahlet Gebremariam, Mitike Molla, Solomon Teferra, Larry Wissow, Andrea Ruff. Background Vertical transmission of HIV remains one of the most common transmission modes. Antiretroviral therapy (ART) decreases the risk of transmission to less than 2%, but maintaining adherence to treatment remains a challenge. Some of the commonly reported barriers to adherence to ART include stress (physical and emotional), depression, and alcohol and drug abuse. Integrating screening and treatment for …
International Journal of Infectious Diseases
20.01.2022
Introduction
PLoS One Infectious Diseases
19.01.2022
by Wondmagegn Tamiru Tadesse, Birhanemeskel T. Adankie, Workineh Shibeshi, Wondwossen Amogne, Eleni Aklillu, Ephrem Engidawork. Objective We investigated prevalence and predictors of glucose metabolism disorders (GMDs) among People Living with HIV (PLWH) on efavirenz- and atazanavir/ritonavir-based combination antiretroviral therapy (cART). Methods This cross-sectional study involved adult PLWH on efavirenz- (n = 240) and atazanavir/ritonavir-based (n = 111) cART. The prevalence of GMDs was determined by …
BMJ Open
18.01.2022
. Objectives. To determine the prevalence of undiagnosed hepatitis C virus (HCV) and HIV cases in a population sample tested in the emergency room (ER) and to evaluate linkage-to-care. . Setting. Canadian university hospital. . Participants. Adults born after 1945 who consulted at ER for any condition and on any shift were included. Patients unable to opt-out were excluded. . Interventions. ER nurse confirmed patients’ eligibility and provided them with the option to opt-out. A physician me…
PLoS One Infectious Diseases
18.01.2022
by Avik Biswas, Allan Haldane, Ronald M. Levy. . The rapid evolution of HIV is constrained by interactions between mutations which affect viral fitness. In this work, we explore the role of epistasis in determining the mutational fitness landscape of HIV for multiple drug target proteins, including Protease, Reverse Transcriptase, and Integrase. Epistatic interactions between residues modulate the mutation patterns involved in drug resistance, with unambiguous signatures of epistasis best seen in the comp…
Journal of the American Medical Association
18.01.2022
A 57-year-old man with HIV (CD4 cell count, 16/mm3; HIV viral load >10 million copies/mL) had blurred vision, weight loss, and gastrointestinal bleeding. A sample of small bowel showed inflammation of the lamina propria, with numerous cytoplasmic and nuclear inclusions with an “owl eye” appearance; dilated retinal examination revealed extensive macular hemorrhage with peripapillary whitening. What is the diagnosis and what would you do next?
Journal of the American Medical Association
18.01.2022
Fewer children and adolescents with HIV infection are close to meeting global viral suppression goals compared with adults, an international research consortium’s study suggested.
Clinical Infectious Diseases
18.01.2022
AbstractBackgroundUptake of HIV preexposure prophylaxis (PrEP) has been increasing in the United States since its FDA approval in 2012; however, the COVID-19 pandemic may have affected this trend. Our objective was to assess the impact of the COVID-19 pandemic on PrEP prescriptions in the United States.MethodsWe analyzed data from a national pharmacy database from January 2017 through March 2021 to fit an interrupted time-series model that predicted PrEP prescriptions and new PrEP users had the pandemic not…
BMC Infectious Diseases
18.01.2022
. Abstract. . Background. Fever of unknown origin (FUO) is a challenge for clinicians treating patients with HIV/AIDS. CD4 counts can be helpful in the diagnosis and treatment. This study aimed to determine several common etiologies of FUO stratified by CD4 count levels in HIV/AIDS patients. . . Methods. A cross-sectional retrospectiv…
BMJ Open
17.01.2022
. Introduction. Despite the success of antiretroviral therapy (ART) in transforming HIV disease into a chronic infection, people living with HIV (PLWH) remain at risk for various non-AIDS inflammatory comorbidities. Risk of non-AIDS comorbidities is associated with gut dysbiosis, epithelial gut damage and subsequent microbial translocation, and increased activation of both circulating CD4+ and CD8+ T-cells. Therefore, in addition to ART, novel gut microbiota-modulating therapies could aid in reducing infl…
Clinical Infectious Diseases
17.01.2022
AbstractBackgroundThe effect of pneumococcal vaccination of mothers with HIV on infant responses to childhood vaccination has not been studied. We compared the immunogenicity of PCV-10 in HIV-exposed uninfected infants born to mothers who received PCV-10, PPV-23 or placebo during pregnancy.MethodsAntibody levels against seven serotypes were measured at birth, before the 1 st and 2 nd doses of PCV-10 and after the completion of the 2-dose regimen in 347 infants, including 112 born to mothers who received PPV…
BMC Infectious Diseases
15.01.2022
. Abstract. . Background. Early start of highly active antiretroviral therapy (HAART) in perinatally HIV-1 infected children is the optimal strategy to prevent immunological and clinical deterioration. To date, according to EMA, only 35% of antiretroviral drugs are licenced in children < 2 years of age and 60% in those aged 2–12 years, due to the lack of adequate paediatric clinical studies on pharmacokinetics…
BMC Infectious Diseases
15.01.2022
. Abstract. . Background. Early start of highly active antiretroviral therapy (HAART) in perinatally HIV-1 infected children is the optimal strategy to prevent immunological and clinical deterioration. To date, according to EMA, only 35% of antiretroviral drugs are licenced in children < 2 years of age and 60% in those aged 2–12 years, due to the lack of adequate paediatric clinical studies on pharmacokinetics…
PLoS One Infectious Diseases
14.01.2022
… Trivino Duran, Vivian Cox, Catherine J. Wedderburn, Janet Giddy, Pauline Pieters, Mark F. Cotton, Tabitha Mutseyekwa, Bulelwa Rorwana, Beryl Sibanda, Jonathan Bernheimer, Nopinky Matise, Petros Isaakidis, Jean Maritz. Background Despite the reduction of HIV mother-to-child transmission, there are concerns regarding transmission rate in the breastfeeding period. We describe the routine uptake of 6 or 10 (6/10) weeks, 9 months and 18 months testing, with and without tracing, in a cohort of infants who recei…
BMJ Open
13.01.2022
. Objectives. Regular HIV testing in men who have sex with men (MSM) enables timely entry into care and reduces the likelihood of HIV transmission. We aimed to assess HIV-testing behaviour and associated factors in MSM by urbanisation of place of residence. . Design. Data were derived from online survey (‘Men & Sexuality’) in the Netherlands, which was mainly advertised on social media (Facebook and Instagram), dating websites, apps for MSM (Grindr and PlanetRomeo) and gay media. . Pr…
PLoS One Infectious Diseases
13.01.2022
by Sophie Degroote, Linos Vandekerckhove, Dirk Vogelaers, Charlotte Vanden Bulcke. Background The use of single-tablet regimens (STRs) in HIV treatment is ubiquitous. However, reintroducing the (generic) components as multi-tablet regimens (MTRs) could be an interesting cost-reducing strategy. It is essential to involve patient-reported outcome measures (PROs) to examine the effects of such an approach. Hence, this study compared PROs of people living with HIV taking an STR versus a MTR in a real world set…
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se
flere resultater her?
Medscape Infectious Diseases
18.01.2022
Gilead Sciences said on Tuesday that tampered and counterfeit versions of its HIV treatments worth $250 million were sold to pharmacies over 2 years by a network of drug distributors and suppliers. .
Morbidity and Mortality Weekly Report (MMWR)
13.01.2022
This report describes a Kanawha County HIV outbreak during the COVID-19 pandemic among people who inject drugs.
Morbidity and Mortality Weekly Report (MMWR)
13.01.2022
This report describes HIV prevalence among young women in Lesotho.
Medscape Infectious Diseases
12.01.2022
Now that medical science has solved the HIV treatment paradigm, it might be time to shift to patient experience to end the AIDS epidemics. .
Medscape Infectious Diseases
5.01.2022
Patient and graft survival outcomes after 15 years support transplant benefits in HIV population. .
Medscape Infectious Diseases
27.12.2021
The first study of its kind shows regional global disparities in COVID-19 vaccination rates among people with HIV, who are at higher risk for COVID-19 mortality. .
Medscape Infectious Diseases
15.12.2021
A study drawn from Kaiser Permanente records indicates increased risk for heart failure among people with HIV infections, especially those younger than 40, female or of Asian/Pacific Islander ancestry.
Medscape Infectious Diseases
13.12.2021
Testing for HIV declined by nearly 50% in 2020 during COVID-19 restrictions; heightened awareness of testing by clinicians urged.
Eurosurveillance latest updates
9.12.2021
Background People who inject drugs (PWID) are frequently incarcerated, which is associated with multiple negative health outcomes. Aim We aimed to estimate the associations between a history of incarceration and prevalence of HIV and HCV infection among PWID in Europe. Methods Aggregate data from PWID recruited in drug services (excluding prison services) or elsewhere in the community were reported by 17 of 30 countries (16 per virus) collaborating in a European drug monitoring system (2006–2020…
Medscape Infectious Diseases
8.12.2021
Since the FDA approved the first pill to prevent HIV in 2012, the medication has been slow to move out of sexual health and infectious disease practices. The new guidelines ask clinicians to step up.
Morbidity and Mortality Weekly Report (MMWR)
2.12.2021
This report describes HIV infections among men who have sex with men and how new infections did not change overall during 2010-2019.
Eurosurveillance latest updates
25.11.2021
Introduction Knowing the factors associated with HIV transmission is necessary in order to design preventive programmes tailored to the epidemiological situation in each region and population. Aim Our objective was to study the sociodemographic, clinical and behavioural characteristics of men who have sex with men (MSM) who were newly diagnosed with HIV infection. Methods We carried out an observational, descriptive, study on all MSM newly diagnosed with HIV infection in one clinic for sexually transm…
Eurosurveillance latest updates
25.11.2021
Background Despite availability of pre-exposure prophylaxis (PrEP), the incidence of HIV-1 in Europe remained stable the past decade. Reduction of new HIV-1 infections requires more knowledge about the profiles of high-risk transmitters and late presenters (LP). Aim We aimed to investigate risk factors associated with HIV-1 transmission clusters and late presentation with HIV-1 in Denmark. Methods Blood samples and epidemiological information were collected from newly diagnosed HIV-1 patients between …
Eurosurveillance latest updates
25.11.2021
Background In Europe, HIV disproportionately affects men who have sex with men (MSM), people who inject drugs (PWID), prisoners, sex workers, and transgender people. Epidemiological data are primarily available from national HIV case surveillance systems that rarely capture information on sex work, gender identity or imprisonment. Surveillance of HIV prevalence in key populations often occurs as independent studies with no established mechanism for collating such information at the European level. Aim We…
Morbidity and Mortality Weekly Report (MMWR)
24.11.2021
This report describes awareness of preexposure prophylaxis among heterosexual adults.
Medscape Infectious Diseases
16.11.2021
Two men have achieved a possible cure through stem cell transplantation. But now, a 30-year-old mother in Argentina shows that the human immune system can, at times, eliminate transmissible HIV all by itself.
Morbidity and Mortality Weekly Report (MMWR)
10.11.2021
This report describes HIV risk among girls and young women in Namibia.
Morbidity and Mortality Weekly Report (MMWR)
21.10.2021
This report describes surveillance of an outbreak of Pediatric HIV in Ratodero, Pakistan.
Morbidity and Mortality Weekly Report (MMWR)
21.10.2021
This report describes HIV prevalence among persons who inject drugs during 2018.
Morbidity and Mortality Weekly Report (MMWR)
7.10.2021
This report describes awareness of preexposure prophylaxis among Hispanic or Latino persons.